Delivery Order SPE2DB20D2104-SPE2DB25FMVTY
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $7,100.31 to AmerisourceBergen Drug Corp for the supply of Vevye 0.1% eye drop in 2ML units. This firm fixed-price delivery order, issued on August 15, 2025, with an ultimate completion date of August 18, 2025, represents a non-competitive award under an existing contract vehicle. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal...
- The Defense Logistics Agency awarded a $1,765.59 firm fixed-price delivery order to AmerisourceBergen Drug Corp for VEVYE 0.1% eye drop solution (2ML) on July 21, 2025, with completion expected by July 22, 2025. This non-set-aside contract represents a child delivery order issued under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion global pharmaceutical support vehicle running through December 2026. The product will be...
- The Defense Logistics Agency awarded a delivery order valued at $1,041.80 to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of VEVYE 0.1% eye drop solution in 2ML units. This is a firm fixed-price delivery order with an ultimate completion date of September 29, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The contract was competitively awarded with no set-aside designation, reflecting AmerisourceBergen's capability to compete in...
- The Defense Logistics Agency awarded a $1,571.97 delivery order to AmerisourceBergen Drug Corp for VEVYE 0.1% eye drop (2ML) on September 26, 2025, with completion scheduled for September 29, 2025. This firm fixed-price contract was competitively awarded with no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal medical procurement vendor that...
- The Defense Logistics Agency awarded a delivery order valued at $1,571.97 to AmerisourceBergen Drug Corp for VEVYE 0.1% eye drop in 2ML units. This firm fixed price delivery order, issued on August 27, 2025, with an ultimate completion date of August 28, 2025, represents a child contract under AmerisourceBergen's larger pharmaceutical supply agreement with DLA. The contract was competitively awarded with no set-aside designation and will be performed at the company's corporate office location in...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,047.98 for VEVYE 0.1% eye drop solution (2ml) on September 25, 2025, with completion scheduled for September 26, 2025. This firm fixed-price contract represents a non-competitive, non-set-aside award and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical vendor for federal...
- The Defense Logistics Agency awarded a delivery order valued at $2,653.69 to AmerisourceBergen Drug Corp for VEVYE 0.1% eye drop solution (2mL) under a firm fixed price contract with an ultimate completion date of July 31, 2025. The award was made on July 30, 2025, without set-aside designation, indicating competitive procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform this delivery order at its corporate office location. This delivery order is...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,519.02 to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Vevye 0.1% eye drop solution (2ML units). This is a firm fixed-price, competitively awarded contract with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with a completion date of September 18, 2025. This delivery order is issued under AmerisourceBergen's broader...
- The Defense Logistics Agency awarded a delivery order valued at $10,103.46 to AmerisourceBergen Drug Corp for VEVYE 0.1% eye drop solution (2ML) on September 8, 2025, with completion scheduled for September 9, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for VEVYE 0.1% eye drop in a 2ml formulation, with a ceiling value of $1,047.98. This competitive delivery order, issued under a firm fixed price arrangement, represents a continuation of pharmaceutical supply support through AmerisourceBergen's broader federal contracting relationship. The award carries no set-aside designation and is set for ultimate completion by August 6, 2025, with...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB25FMVTYDelivery Order
The Defense Logistics Agency (DLA) awarded a $4,116.93 firm fixed price delivery order to AmerisourceBergen Drug Corp for Vevye 0.1% eye drop solution (2mL) on July 17, 2025, with an ultimate completion date of July 18, 2025. The award was made on a competitive basis with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and will perform the work at its corporate office location. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. The delivery order supports DLA's Medical Supply Chain operations, which provision pharmaceutical products and medical supplies to military and federal healthcare systems. AmerisourceBergen's prime IDC vehicle enables the company to supply a comprehensive range of pharmaceuticals, vaccines, and medical commodities across multiple therapeutic domains to support military healthcare programs globally, including the Defense Health Agency and U.S. Coast Guard. The company's demonstrated capability to fulfill federal medical procurement requirements through open competition, combined with its extensive portfolio of pharmaceutical deliveries, positions it as a critical vendor within the federal medical procurement infrastructure.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.1k | 7/17/25 |